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Clinical Uses of Cervical Vestibular-Evoked Myogenic
Potential Testing in Pediatric Patients
Guangwei Zhou, MD, ScD, Jenna Dargie, BS, Briana Dornan, AuD, and Kenneth Whittemore, MD
Abstract: To demonstrate the feasibility and clinical significance
of cervical vestibular-evoked myogenic potential (cVEMP) test in
pediatric patients.
Retrospective review study was conducted in a pediatric tertiary
care facility. A total of 278 patients were identified with adequate
data, including medical notes, results of cVEMP, and imaging
studies.
Among the total of 278 pediatric patients, only 3 children were
not able to finish the cVEMP test successfully. In about 90% of the
cases, the cVEMP test was requested to investigate a patient’s
hearing loss and/or vestibular complaints. Over 90% of the cVEMP
tests were ordered by specialists such as pediatric otolaryngologists
or otologists. Obtained cVEMP results provided useful information
in clinical diagnosis and management in all cases.
It is feasible to conduct cVEMP testing in children, including
infants, and cVEMP testing can provide valuable information in the
diagnosis and management of hearing loss and vestibular
impairment. This simple and noninvasive test should be embraced by
pediatric professionals.
(Medicine 93(4):e37)
Abbreviations: cVEMP = cervical vestibular-evoked myogenic
potential, EVA = enlarged vestibular aqueduct, SSCD = superior
semicircular canal dehiscence.
INTRODUCTION
Since the initial depiction by Colebatch et al about twentyyears ago, vestibular-evoked myogenic potential (VEMP)
has been investigated by clinicians and researchers world-
wide and has become an important part of the comprehensive
vestibular evaluation.1–5 Evoked primarily by intense acous-
tic stimuli such as clicks or tonebursts, VEMP is a short-
latency myogenic reflex mediated via otolith organs (the
saccule and the utricles) and vestibular nerves. VEMP
responses can be recorded from neck muscles, known as
cervical VEMP (cVEMP), or extraocular muscles, also
known as ocular VEMP (oVEMP).6–9 Extensive research
studies have shown that cVEMP test is a useful, noninvasive
method for assessment of otolith function and the functional
integrity of the vestibular nerve.10–14 Clinically, cVEMP test
is relatively easy to perform and well tolerated by patients of
all ages. Complementing the traditional vestibular test battery
such as caloric and rotational test, cVEMP test has been used
in the evaluation of a variety of vestibular disorders,
including Meniere’s disease, vestibular schwannoma, and
labyrinthitis/vestibular neuritis.5,15–19 Moreover, most of the
recent studies have demonstrated cVEMP test to be very
sensitive in detecting inner ear structural anomalies such as
superior semicircular canal dehiscence (SSCD) and enlarged
vestibular aqueduct (EVA).20–24
Although cVEMP has been well studied in animals and
human subjects, the majority of clinical research is focused
on adults while cVEMP studies in children are relatively
insufficient. Early studies of cVEMP testing in children
included small numbers of cases and did not draw significant
attention. The first cVEMP study that included a larger
number of children was reported by Sheykholeslami et al25
in 2005, in which they described their success in conducting
cVEMP test in 12 healthy neonates and 12 neonates with
various otologic disorders. To demonstrate the feasibility of
reliable cVEMP testing in normal children, Kelsch et al26 in
2006 conducted a study of cVEMP test in 30 subjects ages
from 3 to 11 years and established their cVEMP normative
data, including latencies and amplitudes. In subsequent years,
similar cVEMP studies in normal pediatric subjects have
provided further evidence in establishing the cVEMP test as
a valid technique for evaluation of pediatric vestibular
function.27–31 Regarding clinical applications, the cVEMP
test for children with known medical conditions are primarily
limited to the topics of otitis media, ototoxic effects,
congenital hearing loss, and cochlear implants.32–40
In 2006, we started to implement cVEMP test for
children at our facility to meet the increasing demand of
clinical evaluation for pediatric patients with auditory and
vestibular complaints. To demonstrate the clinical value of
cVEMP in children and share our experience of this practice,
we decided to conduct this retrospective review of cVEMP
testing in >200 pediatric cases.
MATERIALS AND METHODS
Our study was approved by the institutional review
board at Boston Children’s Hospital.
Patient Selection
After reviewing all available records, we identified a
total of 278 pediatric patients who underwent cVEMP testing
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between July 2006 and July 2012. All selected cases had
usable records, including physicians’ visit notes, clinical/
working diagnoses, imaging studies, and cVEMP outcomes.
Conducting cVEMP Test and Other Audiologic
Evaluations
Prior to cVEMP testing, all patients had a hearing
evaluation with air and bone conduction threshold testing.
Tympanometry and acoustic reflex thresholds were also
obtained if clinically warranted. We used a commercial evoked
potential system (NavigatorPro, Natus Medical Inc., San
Carlos, CA) to record cVEMP under a customized pediatric
protocol. All normative cVEMP parameters, including
threshold, amplitude and latencies, were established at our
facility. The details of the protocol can be found in our
previous publications.24,37 Briefly, acoustic stimuli (500Hz
tonebursts and/or clicks) were presented via insert phones or
bone oscillator. All cVEMP was recorded from sternocleido-
mastoid muscle. Head-turning is required to have sternocleido
mastoid muscle contracted and the contraction is monitored to
ensure its appropriateness. For younger children, an assistant
was employed to attract the patients’ attention, allowing them
to make a head turn to toys with colorful lights. To obtain
cVEMP thresholds, a stimulus level of 90dB normal hearing
level (nHL) was used as the default starting intensity. The
stimulus intensity would decrease in steps of 10dB or increase
in steps of 5dB depending upon the presence or absence of
cVEMP, respectively. The lowest stimulus intensity at which a
clear and repeatable wave was observed would be recorded as
the cVEMP threshold. Amplitude and latency were measured
respective to the cVEMP response to stimuli presented at 90
dB nHL. If no reliable response was found at the maximal
stimulation level, the cVEMP would be considered absent. For
patients with middle ear pathologies and conductive hearing
loss, bone-conducted stimuli were also used to elicit cVEMP if
air-conducted stimuli were not sufficient.
Data analysis
We exclusively used descriptive analysis in this study.
Age, sex, reasons for cVEMP test, referring physician, and
so on were summarized for all patients.
RESULTS
General Information
Among the 278 patients included in this study, there were
119 boys and 159 girls. The average age was 10.5 years (SD¼
4.6), with the youngest at the age of 5 months. To better
demonstrate patients’ makeup, we classified them into 6 age
groups, from the youngest group of “Age 3 & Under” to the
oldest group of “Age 16 to 18”, as shown in Figure 1. Notably,
there were a significant number of children in each age group,
and even in the youngest group there were >20 children
although the Age 13 to 15 group had the largest case number
at 72 (259% of the total). Similarly, we divided the numbers of
cVEMP testing conducted by calendar year, demonstrated in
Figure 2. As shown, we have conducted 30 to 50 cVEMP tests
in pediatric patients each year, except the beginning year of
2006. Of note, the number of cVEMP performed trended
toward to an increase in 2012 since the number in 2006 and
2012 reflected only 6 months of clinical work.
VEMP Referrals
Various reasons for cVEMP testing were documented in
patients’ medical records and these were summarized in
Table 1. As listed, the main reason for requesting a cVEMP
test was to evaluate children’s dizziness, vertigo or balance
issues, and accounted for almost 45% of the total requests. The
second leading reason for cVEMP testing in our facility was
pre- and postcochlear implant workup that accounted for nearly
15%. Investigation of middle ear–related conductive hearing
loss and inner ear structural anomalies such as SSCD and EVA
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FIGURE 1. Enumerated data of pediatric VEMP test conducted in 6 age groups.
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by cVEMP testing, accounted for 13.7% and 11.9% respective-
ly. Twelve children with sensorineural hearing loss caused by
unknown etiology underwent cVEMP testing because of a
concern of possible coexisting vestibulopathy. Ten children
with postconcussion syndrome also underwent cVEMP testing
as a part of a comprehensive workup. The remaining 21
children, 7.5% of the total, were referred for other nonspecific
complaints such as tinnitus or headache.
In addition to tracking the reasons for cVEMP test, we
also looked over the referring physicians and their specialties.
As shown in Table 2, the overwhelming majority of patients
were referred by pediatric otolaryngologists (about 48%) and
otologists/neurotologists (45%). Referrals by neurologists and
neurosurgeons accounted for only 5%. Fewer than 3% of the
referrals originated from other specialists such as audiologists.
Outcomes of cVEMP in Pediatric Patients
Among the 278 children in this study, only 3 children
were not able to complete cVEMP testing, mostly due to fears
of recording electrodes and wires, or they were intolerant of
insert phones. VEMP results obtained from the remaining 275
children were analyzed. If no repeatable cVEMP responses
were present at the highest intensity of the stimuli, we would
call the cVEMP absent. If present, the cVEMP threshold would
be determined along with the cVEMP latency and amplitude,
as described in the method section. Abnormal cVEMP out-
comes found in each referring category are summarized in
Table 3. As shown, abnormal cVEMP responses were found in
all children with conductive hearing loss related to middle ear
pathologies, most had absent cVEMP responses to air-con-
ducted stimuli; however, robust cVEMP were present when
bone-conducted stimuli were used in these cases. Also, the
cVEMP seemed to be very responsive, at 94%, to inner ear
structural anomalies such as EVA and SSCD. Typical cVEMP
findings related to EVA and SSCD included a lower cVEMP
threshold and higher amplitude. In children with cochlear
implant(s), abnormal cVEMPs (absent cVEMP, elevated
cVEMP thresholds, and reduced amplitude) were found in 35
of 40 cases. Only 25% of children with complaints of dizziness
or vertigo had an abnormal cVEMP. Approximately two-thirds
of the children with congenital hearing loss had abnormal
cVEMP, indicating possible cochlear-vestibulopathy although
the exact etiology is unknown. Overall, abnormal cVEMP
results were found in 54% of children who completed the test.
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FIGURE 2. Numbers of pediatric VEMP test conducted in each calendar year at our facility from 2006 to 2012. Of note, the number
in 2006 and 2012 reflected only 6 months of clinical work.
TABLE 1. Summarization of Reasons for Requesting VEMP Testing in Our Study
Reasons for Requesting VEMP test Number of Cases Percentage, %
Dizziness/vertigo/balance problems 124 44.6
Pre-/postcochlear implantation evaluation 40 14.4
Conductive loss due to middle ear involvements 38 13.7
Suspicion of inner ear structural anomalies 33 11.9
Sensorineural hearing loss with unknown etiology 12 4.3
Postconcussion syndrome workups 10 3.6
Other nonspecific complaints 21 7.5
Total 278 100
VEMP ¼ vestibular-evoked myogenic potential.
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DISCUSSION
Our study has revealed a successful experience of
carrying out cVEMP testing in pediatric patients, from
infants to teenagers, in a busy clinical setting. In fact,
cVEMP testing is a noninvasive procedure and is generally
well tolerated by children of all ages. Although the
literatures on cVEMP testing in children revealed its
feasibility, many pediatric professionals have reservations
about the clinical value of cVEMP testing, considering most
of the published studies were conducted using normal
subjects or had a limited number of children.20,29,31,33,41,42 In
fact, a recent survey completed by our group presented a
dismal picture of the use of cVEMP test in children
currently: among the 117 pediatric otolaryngologists who
finished our online survey, about 90% believed that cVEMP
test cannot be performed in children and more than 80%
thought cVEMP testing was unreliable (unpublished data).
One encouraging finding from the survey, however, was that
the majority of pediatric otolaryngologists have basic
knowledge about the test. Consequently, we determined to
conduct this current study to demonstrate that cVEMP testing
not only is feasible but also has clinical value in evaluating
pediatric patients for a variety of clinical scenarios.
We have shown, for the first time, a variety of clinical
applications of cVEMP testing in a large group of pediatric
patients. The sensitivity of the cVEMP test may vary
depending upon the medical conditions present or referring
diagnoses. When middle ear pathology associated conductive
hearing loss is suspected, our study demonstrated 100%
sensitivity of the cVEMP test to confirm such conditions.
Specifically, the cVEMP is absent when air-conducted
stimuli are used to elicit the cVEMP response. In contrast,
cVEMP is usually present if bone-conducted stimuli are used
to elicit response, indicating the existence of a sound
transmission problem via the middle ear system. Also,
cVEMP test has shown to be very sensitive to detect inner
ear structural anomalies such as EVA or SSCD, especially
when conductive hearing loss or air-bone gaps are exhibited
on the audiogram. Although our study showed a relatively
low sensitivity of cVEMP test in evaluating children with
dizziness, vertigo, or balance problem, and its diagnostic
value should not be overlooked. In these circumstances, the
cVEMP test can only assess the otolith function without
semicircular canal function involved, which is a limitation.
Therefore, cVEMP test can be a complimentary procedure to
standard rotational and caloric test.
Conducting VEMP test in pediatric patients, especially in
young children can be a challenge. Most older children (i.e.,
age 7 to 18 years, can follow instructions during cVEMP
testing and make proper head turns to achieve sufficient
muscle contraction. When testing younger children (e.g., age 4
to 6 years), on the other hand, an assistant will be helpful to
draw patients’ attention so that valid cVEMP responses can be
recorded. For younger children who are unable or unwilling to
sit by themselves, sitting in their parents’ lap can be adopted to
have a better control of the patients. Light-up toys are effective
tools to attract patients’ attention but any noise-making toys
should be avoided. It’s also important to allow ample time for
younger children to “warm-up” before putting recording
electrodes and insert phones on them so that their fear of the
testing procedure can be reduced.
CONCLUSION
Based on our clinical experience, cVEMP test can be
successfully conducted in pediatric patients. Conducting
cVEMP test is not only feasible but also valuable in the
clinical evaluation of children with auditory and/or vestibular
TABLE 2. Breakdown of Referrals by Specialists for VEMP Testing in Our Study
Referring Doctors Number of Cases Percentage, %
Pediatric otolaryngologist 133 47.8
Otologist/neurotologist/otoneurologist 125 45.0
Neurologist 11 3.9
Neurosurgeon 3 1.1
Others 6 2.2
Total 278 100
VEMP ¼ vestibular-evoked myogenic potential.
TABLE 3. Occurrence of Abnormal VEMP Results in 275 Pediatric Patients
Abnormal VEMP Outcomes in Each Category Number of Cases Percentage of Abnormal, %
Dizziness/vertigo/balance problems 30/121 25
Pre-/postcochlear implantation evaluation 35/40 88
Conductive loss due to middle ear involvements 38/38 100
Suspicious of inner ear structural anomalies 31/33 94
Sensorineural hearing loss with unknown etiology 8/12 67
Postconcussion syndrome workups 2/10 20
Other nonspecific complaints 4/21 19
Total 148/275 54
VEMP = vestibular-evoked myogenic potential.
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complaints. Although the sensitivity of cVEMP test may vary
depending upon medical conditions, it provides diagnostic
information in most cases. This noninvasive and low-cost test
procedure can be easily implemented in any audiologic clinic
where an evoked potential recording system is available. Most
importantly, pediatric professionals should embrace this
cutting-edge technology and consider cVEMP testing before
ordering more expensive tests such as MRI and CT scans,
which usually bring unpleasant experiences to pediatric
patients.
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